| Date Filed | Type | Description |
| 05/31/2023 |
4
| Kidron Miriam (Chief Scientific Officer) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Granted 53,500 shares
@ $0 |
|
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2023 |
4
| Kidron Miriam (Chief Scientific Officer) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Sold 100,000 shares
@ $2.01, valued at
$201k
|
|
| 08/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| Kidron Miriam (Chief Scientific Officer) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Granted 42,000 shares
@ $0
Granted 72,000 options to buy
@ $13.89, valued at
$1M
|
|
| 09/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/14/2020 |
4
| Kidron Miriam (Chief Scientific Officer) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Granted 100,000 options to buy
@ $4.8, valued at
$480k
|
|
| 09/16/2019 |
4
| Kidron Miriam (Chief Scientific Officer) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Disposed/sold 104,000 options to buy
@ $3.16, valued at
$328.6k
Granted 104,000 options to buy
@ $3.16, valued at
$328.6k
|
|
| 02/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2018 |
4
| Kidron Miriam (Chief Scientific Officer) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Granted 47,000 options to buy
@ $8.14, valued at
$382.6k
|
|
| 08/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/31/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/25/2015 |
4
| Kidron Miriam (Chief Technology Officer) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Granted 79,848 shares
@ $0 |
|
| 11/17/2014 |
4
| Kidron Miriam (Chief Technology Officer) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Granted 9,788 shares
@ $0 |
|
| 09/12/2014 |
4
| Kidron Miriam (Chief Technology Officer) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Sold 23,000 shares
@ $8.4026, valued at
$193.3k
Sold 8,699 shares
@ $8.4379, valued at
$73.4k
|
|
| 09/08/2014 |
4
| Kidron Miriam (Chief Technology Officer) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Sold 8,301 shares
@ $9.4099, valued at
$78.1k
|
|
| 08/01/2014 |
4
| Kidron Miriam (Chief Technology Officer) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Exercised 142,814 warrants
@ $0.012, valued at
$1.7k
|
|
| 04/11/2014 |
4
| Kidron Miriam (Chief Technology Officer) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Granted 47,134 options to buy
@ $12.45, valued at
$586.8k
|
|
| 04/03/2014 |
4
| Kidron Miriam (Chief Technology Officer) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Sold 137,300 shares
@ $12.029, valued at
$1.7M
Exercised 137,300 warrants
@ $0.012, valued at
$1.6k
|
|
| 02/03/2014 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/11/2013 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 11/23/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/09/2012 |
4
| Kidron Miriam (Chief Technology Officer) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Granted 864,000 options to buy
@ $0.34, valued at
$293.8k
|
|
| 05/03/2010 |
4
| Kidron Miriam (Chief Medical &Tech Officer) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Granted 864,000 options to buy
@ $0.49, valued at
$423.4k
|
|